Shimadzu’s New Shim-Pack Arata LC Columns Provide Unprecedented Resolution and Peak Shape of Basic Compounds

Mar 08 2019 Shimadzu Scientific Instruments (SSI) announces the release of the new Shim-pack Arata LC columns to provide unmatched peak shape for high pH compounds. These columns solve the resolution challenges of analyzing basic compounds, such as leading of highly polar basic compounds, peak shape deterioration of acidic compounds, or long equilibration time required... Read more

MilliporeSigma Brings Science Education to Students Across North America with Curiosity Cube® Mobile Science Lab

Burlington, Massachusetts, March 7, 2019 — MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour. “We’ve seen firsthand how the interactive learning that takes place inside the Curiosity Cube® can spark curiosity crucial for developing a passion for science,” said Udit Batra, CEO, MilliporeSigma. “We will continue to... Read more

Agilent and Imperial College London Strengthen Partnership

Agilent and Imperial College London Strengthen Partnership Agilent Measurement Suite at Imperial to boost research in molecular sciences SANTA CLARA, Calif., March 6, 2019 Agilent Technologies Inc. (NYSE: A) and Imperial College London have announced that, as part of its ongoing collaboration, several state-of-the-art analytical instruments have been installed into the college’s Molecular Sciences Research... Read more

Open Letter to Versum Shareholders from Merck KGaA, Darmstadt, Germany

05 MAR 2019 | DARMSTADT, GERMANY Merck KGaA, Darmstadt, Germany, a leading science and technology company, today issued an open letter to the shareholders of Versum Materials, Inc. (“Versum”). On March 1, the Versum Board of Directors without any further explanation rejected Merck KGaA, Darmstadt, Germany’s superior proposal to acquire all of the outstanding common stock of... Read more

MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

04 MAR 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks MilliporeSigma’s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Burlington, Massachusetts, March 4, 2019 – MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed... Read more

Bruker Expands Pharma and Industrial NMR, EPR and Software Solutions

HILTON HEAD ISLAND, South Carolina, March 4, 2019: Bruker is expanding its pharma and industrial NMR, EPR and related software solutions at PANIC 2019, the ‘Practical Applications of NMR in Industry Conference’ (www.panicnmr.com). The new productivity and compliance tools include: New Compliance Tools for Regulated Markets: Adherence to compliance with GxP is mandatory in regulated environments of... Read more

Bruker Announces Progress in Advanced Methods and Software Tools for 4D High-Throughput and Ultra-High Sensitivity Proteomics

– High-throughput clinical plasmaproteomics research: 192 depleted plasma samples from septic shock patients measured in 2 days, with 11.5 minute gradients on 100 ng/run – Enhanced proteomics data completeness: MaxQuant ‘match-between-runs’ with large-scale CCS values for dramatic improvements in peptide and protein data completeness – Host cell protein (HCP) analysis for biologics: Protein Metrics adds... Read more

Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 13, 2019

Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 13, 2019 WALTHAM, Mass., March 4, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019,... Read more

Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering WASHINGTON, March 1, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred... Read more

Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle Inc.

Indianapolis, Indiana (February 28, 2019) – At the Advances in Genome Biology and Technology (AGBT) General Meeting*, Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company. As cfDNA workflows move beyond theoretical and into human health applications, Apostle’s industry leading chemistry... Read more